Amro Alshareef

Amro Alshareef

Auto-generated profile, based on publicly available information

Amro Alshareef

Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in Science Robotics
Verified
Journal Article
Closed access
HHHugh Herr
Hugh Herr
AAAmro Alshareef
Amro Alshareef
AHAlexandria V. Hwang
Alexandria V. Hwang
ZKZiliang Kang
Ziliang Kang
JKJohannes Kuosmanen
Johannes Kuosmanen
GTGiovanni Traverso
Giovanni Traverso
Oral drug delivery of proteins is limited by the degradative environment of the gastrointestinal tract and poor absorption, requiring parenteral administration of these drugs. Luminal mucus represents the initial steric and dynamic barrier to absorption. To overcome this barrier, we report the development of the RoboCap, an orally ingestible, robotic drug delivery capsule that locally clears the mucus layer, enhances luminal mixing, and topically deposits the drug payload in the small intestine to enhance drug absorption. RoboCap’s mucus-clearing and churning movements are facilitated by an internal motor and by surface features that interact with small intestinal plicae circulares, villi, and mucus. Vancomycin (1.4 kilodaltons of glycopeptide) and insulin (5.8 kilodaltons of peptide) delivery mediated by RoboCap resulted in enhanced bioavailability 20- to 40-fold greater in ex vivo and in vivo swine models when compared with standard oral delivery ( P < 0.05). Further, insulin delivery via the RoboCap resulted in therapeutic hypoglycemia, supporting its potential to facilitate oral delivery of drugs that are normally precluded by absorption limitations.

22 December 2023 in Science Advances
Verified
Journal Article
Open access
HHHugh Herr
Hugh Herr
AAAmro Alshareef
Amro Alshareef
AHAlexandria Hwang
Alexandria Hwang
CBCeara Byrne
Ceara Byrne
JKJohannes Kuosmanen
Johannes Kuosmanen
GTGiovanni Traverso
Giovanni Traverso
Effective therapies for obesity require invasive surgical and endoscopic interventions or high patient adherence, making it challenging for patients with obesity to effectively manage their disease. Gastric mechanoreceptors sense distension of the stomach and perform volume-dependent vagal signaling to initiate the gastric phase and influence satiety. In this study, we developed a new luminal stimulation modality to specifically activate these gastric stretch receptors to elicit a vagal afferent response commensurate with mechanical distension. We designed the Vibrating Ingestible BioElectronic Stimulator (VIBES) pill, an ingestible device that performs luminal vibratory stimulation to activate mechanoreceptors and stroke mucosal receptors, which induces serotonin release and yields a hormonal metabolic response commensurate with a fed state. We evaluated VIBES across 108 meals in swine which consistently led to diminished food intake (~40%,P< 0.0001) and minimized the weight gain rate (P< 0.05) as compared to untreated controls. Application of mechanoreceptor biology could transform our capacity to help patients suffering from nutritional disorders.

28 February 2024 in Science Robotics
Verified
Journal Article
Closed access
HHHugh Herr
Hugh Herr
JDJulien Dosso
Julien Dosso
HHHen-Wei Huang
Hen-Wei Huang
GSGeorge Selsing
George Selsing
AAAmro Alshareef
Amro Alshareef
GTGiovanni Traverso
Giovanni Traverso
Postoperative ileus (POI) is the leading cause of prolonged hospital stay after abdominal surgery and is characterized by a functional paralysis of the digestive tract, leading to symptoms such as constipation, vomiting, and functional obstruction. Current treatments are mainly supportive and inefficacious and yield acute side effects. Although electrical stimulation studies have demonstrated encouraging pacing and entraining of the intestinal slow waves, no devices exist today to enable targeted intestinal reanimation. Here, we developed an ingestible self-propelling device for intestinal reanimation (INSPIRE) capable of restoring peristalsis through luminal electrical stimulation. Optimizing mechanical, material, and electrical design parameters, we validated optimal deployment, intestinal electrical luminal contact, self-propelling capability, safety, and degradation of the device in ex vivo and in vivo swine models. We compared the INSPIRE’s effect on motility in models of normal and depressed motility and chemically induced ileus. Intestinal contraction improved by 44% in anesthetized animals and up to 140% in chemically induced ileus cases. In addition, passage time decreased from, on average, 8.6 days in controls to 2.5 days with the INSPIRE device, demonstrating significant improvement in motility. Luminal electrical stimulation of the intestine via the INSPIRE efficaciously restored peristaltic activity. This noninvasive option offers a promising solution for the treatment of ileus and other motility disorders.

10 August 2025 in Nature Communications
Verified
Journal Article
Open access
HHHugh Herr
Hugh Herr
MAMarc-Joseph Antonini
Marc-Joseph Antonini
AAAmro Alshareef
Amro Alshareef
ASAtharva Sahasrabudhe
Atharva Sahasrabudhe
JJJosh Jenkins
Josh Jenkins
GTGiovanni Traverso
Giovanni Traverso
Gastrointestinal (GI) dysmotility and associated conditions affect over 20% of population, yet pharmacological, behavioural, and surgical interventions offer limited therapeutic efficacy. Targeted electrical stimulation addressing underlying neuromuscular pathology stands to transform our ability to treat dysmotility. Here, we developed a closed-loop GI neuroprosthesis which activates or relaxes GI tract musculature through electrochemical stimulation in response to sensed food stimuli. We additionally describe a tool supporting minimally invasive endoscopically guided implantation that can penetrate the mucosa, accurately localize the submucosa, and safely deploy this device to directly interface with the enteric nervous system. The neuroprosthesis enables generation of coordinated peristaltic waves, significantly increasing the motility rate in a swine model of oesophageal and stomach dysmotility (p < 0.05, student's t-test). Further, by directly modulating the myenteric plexus and thus mimicking meal ingestion, we induce peristalsis in a fasted state and achieve a metabolic response commensurate with a fed or satiated state. This neuroprosthesis and implantation platform expand opportunities in fundamental studies and treatments of metabolic and neuromuscular pathologies affecting the GI tract.

19 July 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
HHHugh Herr
Hugh Herr
AAAmro Alshareef
Amro Alshareef
AHAlexandria Hwang
Alexandria Hwang
CBCeara Bryne
Ceara Bryne
JKJohannes Kuosmann
Johannes Kuosmann
GTGiovanni Traverso
Giovanni Traverso
Effective therapies for obesity either require invasive surgical or endoscopic interventions or high patient adherence, making it challenging for the nearly 42% of American adults who suffer from obesity to effectively manage their disease. Gastric mechanoreceptors sense distension of the stomach and perform volume-dependent vagal signaling to initiate the gastric phase and influence satiety. In this study, we developed a new luminal stimulation modality to specifically activate these gastric stretch receptors to elicit a vagal afferent response commensurate with mechanical distension. Here we developed the Vibrating Ingestible BioElectronic Stimulator (VIBES) pill - an ingestible device that performs luminal vibratory stimulation to activate mechanoreceptors and stroke mucosal receptors, which induces serotonin release as well as yields a hormonal metabolic response commensurate with a fed state. We evaluated VIBES across 108 meals in swine which consistently led to diminished food intake (∼40%, p< 0.0001) and minimized the weight gain rate (p< 0.03) as compared to untreated controls. Application of mechanoreceptor biology could transform our capacity to help patients suffering from nutritional disorders.

5 November 2025 in bioRxiv
Verified
Preprint
Open access
AAAmro A. Alshareef
Amro A. Alshareef
PNPaul Nardelli
Paul Nardelli
SSSurabhi N. Simha
Surabhi N. Simha
TCTimothy C. Cope
Timothy C. Cope
LTLena H. Ting
Lena H. Ting
GSGregory S. Sawicki
Gregory S. Sawicki
Exoskeletons assist and augment human movement, but their effects on proprioceptive feedback remain poorly understood. We examined how parallel exoskeleton stiffness influences primary muscle spindle firing. In an anesthetized rat preparation, controlled stretches of the medial gastrocnemius were applied with springs (0–0.5 N/mm) attached in parallel to the muscle-tendon unit (MTU) to simulate passive exoskeleton assistance. Fascicle length was measured with sonomicrometry, force and MTU length with a servo motor, and spindle instantaneous firing rate (IFR) with dorsal root recordings. Increasing exoskeleton stiffness decreased biological muscle force (3.1 ± 0.6 N to 1.6 ± 0.6 N, p < 0.001) and stiffness (4.4 ± 1.5 N/mm to 2.3 ± 1.3 N/mm, p < 0.01), while fascicle length increased (7.9 ± 1.3 mm to 8.3 ± 1.5 mm, p < 0.005). Despite these altered mechanics, spindle firing did not significantly change, and showed weak correlations with muscle length, velocity, force, and yank (R 2 ≤ 0.14). These results indicate that exoskeleton stiffness modifies fascicle dynamics without altering spindle firing. Previously proposed models of primary afferent firing did not sufficiently explain these results. This is the first in situ investigation of exoskeleton effects on primary afferent feedback during active contractions.